BMS-214662
As of the edition of 20 October 2026, BMS-214662 is a small molecule: went quiet in 2002; acts on FNTB.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Went quiet, 2002
- Kind
- Small molecule
- Registered trials
- 6, 0 stopped early
- Disease areas
- Cancer; Blood and lymph; Immune system
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| FNTB | Protein farnesyltransferase subunit beta | P49356 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 6 | 6 | 0 | 0 |
| All trials | 6 |